Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study.

about

Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study.

Item

http://www.wikidata.org/entity/Q40716131

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study.

@en

type

Item

label

Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study.

@en

prefLabel

Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study.

@en

P1476

Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study

@en

P2093

Alessandro Negrinelli

http://www.w3.org/2001/XMLSchema#string

Anna Paini

http://www.w3.org/2001/XMLSchema#string

Claudia Agabiti Rosei

http://www.w3.org/2001/XMLSchema#string

Enrico Agabiti Rosei

http://www.w3.org/2001/XMLSchema#string

Giampaolo Merlini

http://www.w3.org/2001/XMLSchema#string

Gina Gregorini

http://www.w3.org/2001/XMLSchema#string

Giovanni Cancarini

http://www.w3.org/2001/XMLSchema#string

Giulia Rubagotti

http://www.w3.org/2001/XMLSchema#string

Maria Lorenza Muiesan

http://www.w3.org/2001/XMLSchema#string

Massimo Salvetti

http://www.w3.org/2001/XMLSchema#string

P2860

A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease

Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.

Apolipoprotein A-I-derived amyloid in atherosclerosis. Its association with plasma levels of apolipoprotein A-I and cholesterol.

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study.

Expert consensus document on arterial stiffness: methodological issues and clinical applications.

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

The effects of altered apolipoprotein A-I structure on plasma HDL concentration.

P304

187-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13506129.2015.1066771

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26193960

http://www.w3.org/2001/XMLSchema#string